IP Library Granted Patent US 7,875,709
Granted Patent B2
US 7,875,709 · App. 12/404,458 · Granted Jan 25, 2011

Nucleic acids encoding interleukin-18 mutants

Assignee: Ares Trading S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,709
App. No.
12/404,458
Granted
Jan 25, 2011
Kind
B2
Abstract

The invention provides mutants of IL-18 with lower affinity to IL-18BP than the wild type IL-18 molecule.

Claims (18)

1. An isolated DNA encoding an interleukin-18 (IL-18) polypeptide comprising the amino acid sequence of SEQ ID NO: 2, except that one or more amino acid residues selected from the group consisting of Glu-42, Ile-85, Met-87, Lys-89, Met-96, Asp-130, Lys-132, Pro-143, Met-149, and Leu-189 are mutated.

2. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:3.

3. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of encoding the polypeptide of SEQ ID NO:4.

4. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of encoding the polypeptide of SEQ ID NO:5.

5. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of encoding the polypeptide of SEQ ID NO:6.

6. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of encoding the polypeptide of SEQ ID NO:7.

7. The isolated DNA according to claim 1 , wherein the polypeptide comprises the amino acid sequence of encoding the polypeptide of SEQ ID NO:8.

8. The isolated DNA according to claim 1 further comprising a nucleic acid molecule a signal peptide.

9. The isolated DNA according to claim 8 , wherein the signal peptide is that of a growth hormone.

10. A vector comprising the isolated DNA according to claim 1 , wherein said vector is capable of expressing the polypeptide encoded by said isolated nucleic acid in an appropriate host cell.

11. The vector according to claim 10 , wherein the host cell is prokaryotic.

12. The vector according to claim 11 , wherein the DNA encodes a polypeptide selected from a group consisting of SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5.

13. The vector according to claim 10 , wherein the host cell is a eukaryotic cell.

14. The vector according to claim 13 , wherein the DNA encodes a polypeptide selected from a group consisting of SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8.

15. The vector according to claim 13 , comprising an isolated DNA according to claim 8 .

16. The vector according to claim 13 , comprising an isolated DNA according to claim 9 .

17. The vector according to claim 14 , wherein said DNA is ligated to DNA encoding the human growth hormone signal peptide.

18. A pharmaceutical composition comprising an isolated DNA molecule according to claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2009
From: DINARELLO, CHARLES A.; KIM, SOO-HYUN
To: ARES TRADING, S.A.
Reel/Frame 022944/0554 →
Continuity (3)
Division 1009415300 · Mar 8, 2002
Provisional Application 6027432700 · Mar 8, 2001
Related Publication 20090286855A1 · Nov 19, 2009